Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEE.PRS
2476
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.13B
| $3.33M | ﹤0.01% |
66,728
-588
| -0.9% | -$28.9K |
|
2477
Interface
TILE
$2.03B
| $3.32M | ﹤0.01% |
114,864
-32,467
| -22% | -$819K |
|
2478
BrightSpring Health Services Unit
BTSGU
$1.62B
| $3.32M | ﹤0.01% |
32,816
| – | – |
|
2479
Trustmark
TRMK
$2.8B
| $3.31M | ﹤0.01% |
83,551
-42,992
| -34% | -$1.68M |
|
2480
CALL
Cadiz
CDZI
$260M
| $3.3M | ﹤0.01% |
700,000
+186,700
| +36% | +$652K |
|
2481
CALL
AMC Entertainment Holdings
AMC
$2.54B
| $3.3M | ﹤0.01% |
1,138,700
+1,000,000
| +721% | +$2.97M |
|
2482
CALL
Toast
TOST
$19B
| $3.29M | ﹤0.01% |
+90,000
| New | +$3.91M |
|
2483
Mercury Insurance
MCY
$5.94B
| $3.28M | ﹤0.01% |
38,681
-98,978
| -72% | -$7.3M |
|
2484
United Fire Group
UFCS
$1.34B
| $3.27M | ﹤0.01% |
107,503
-10,479
| -9% | -$309K |
|
2485
Ducommun
DCO
$2.76B
| $3.27M | ﹤0.01% |
33,994
-9,487
| -22% | -$857K |
|
2486
Trinity Industries
TRN
$2.5B
| $3.26M | ﹤0.01% |
116,406
-90,426
| -44% | -$2.49M |
|
2487
PUT
Remitly
RELY
$5.05B
| $3.26M | ﹤0.01% |
+200,000
| New | +$3.59M |
|
2488
Choice Hotels
CHH
$4.93B
| $3.26M | ﹤0.01% |
30,488
+17,113
| +128% | +$2.09M |
|
2489
CorVel
CRVL
$3.09B
| $3.23M | ﹤0.01% |
41,692
-15,773
| -27% | -$1.41M |
|
2490
Akebia Therapeutics
AKBA
$351M
| $3.22M | ﹤0.01% |
1,180,233
+195,721
| +20% | +$651K |
|
2491
Papa John's
PZZA
$1.02B
| $3.22M | ﹤0.01% |
66,882
-304,237
| -82% | -$14.1M |
|
2492
Phinia Inc
PHIN
$2.86B
| $3.21M | ﹤0.01% |
55,921
-22,303
| -29% | -$1.2M |
|
2493
Central Garden & Pet Co Class A
CENTA
$2.39B
| $3.21M | ﹤0.01% |
108,834
-22,056
| -17% | -$734K |
|
2494
Envista
NVST
$4.45B
| $3.21M | ﹤0.01% |
157,751
+53,676
| +52% | +$1.1M |
|
|
TIC
2495
TIC Solutions Inc
TIC
$1.73B
| $3.19M | ﹤0.01% |
239,996
+51,092
| +27% | +$583K |
|
2496
O-I Glass
OI
$1.14B
| $3.19M | ﹤0.01% |
246,011
-45,859
| -16% | -$625K |
|
2497
AvePoint
AVPT
$2.83B
| $3.18M | ﹤0.01% |
211,537
-53,734
| -20% | -$902K |
|
2498
Wolverine World Wide
WWW
$1.62B
| $3.17M | ﹤0.01% |
115,553
-44,000
| -28% | -$1.16M |
|
2499
Teck Resources
TECK
$29.5B
| $3.17M | ﹤0.01% |
72,184
-379,046
| -84% | -$13.8M |
|
2500
Zevra Therapeutics
ZVRA
$594M
| $3.16M | ﹤0.01% |
332,443
+228,092
| +219% | +$2.29M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.